Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Articles published by Tevogen Bio Inc

< Previous 1 2 3 4 Next >
Tevogen Marks Major Milestone in Its AI Initiative to Enhance Efficacy of T Cell–Based Therapies with 100x PredicTcell™ Beta Data Expansion
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Highlights Potential Role of TVGN 489 in Eliminating Persistent Viral Reservoirs Linked to Long COVID
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489’s Potential Impact for 20 Million Americans
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Join Startup Forum Panel at Databricks DATA + AI World Tour in Boston
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Estimates 5-Year Top-Line Revenue of ∼$6.5 Billion For Product Focused on Liver Cancer Prevention with High-Risk Chronic Hepatitis B Infection
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Values TVGN-489 at $9–$11 Billion rNPV, Its First Clinical Product From the Proprietary ExacTcell™ Allogeneic T Cell Platform
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Shares Valuation of Key Assets and Potential Forecast For Pipeline Product Focused on EBV Associated Leukemia and Lymphomas
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Underscores the Importance of Precision Immunotherapies, Including TVGN 489 for Vulnerable Individuals Infected with SARS-CoV-2
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Bio Highlights Proprietary Assets and Upcoming Valuation Disclosure
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Expresses Gratitude to Yale for Recognition of Dr. Ryan Saadi and Company’s Mission of Health Equity
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Sees Continued Growth in Institutional Ownership in Q2 2025; 72% of Holders Increased or Maintained Positions
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen CEO Donates Personal Shares to Support Local Law Enforcement
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Repeat - Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
From Tevogen Bio Inc
Via GlobeNewswire
Tickers MSFT TVGN TVGNW
Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
REPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
REPEAT - Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
From Tevogen Bio Inc
Via GlobeNewswire
Tickers MSFT TVGN TVGNW
Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision
From Tevogen Bio Inc
Via GlobeNewswire
Tickers TVGN TVGNW
Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare
From Tevogen Bio Inc
Via GlobeNewswire
Tickers MSFT TVGN TVGNW
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.